Asgard Therapeutics AB

https://www.asgardthx.com

LinkedIn: https://www.linkedin.com/company/asgardthx

Asgard Therapeutics is a privately held preclinical stage biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy. The company builds on ground-breaking and proprietary reprogramming technologies to develop gene therapy products designed to set in motion efficient and personalized immune responses. Backed by Johnson & Johnson Innovation – JJDC, Inc., RV Invest, Novo Holdings, Boehringer Ingelheim Venture Fund, and Industrifonden, Asgard Therapeutics aims to establish a pipeline of off-the shelf cancer immunotherapies that trigger personalized anti-cancer immune responses for the benefit of cancer patients in need. *

	Start	2021-03-29 existent (s-offbef)
	Predecessor	University of Lund (Lund University)
	Industry	BIOTECH
	Industry 2	TrojanDC technology
	Person	Pires, Cristiana F. (Asgard Therapeutics 202111 CEO + Co-Founder)

	Region	Lund
	Country	Sweden
	Street	2 Scheelevägen Medicon Village
	City	22381 Lund
	Tel	+46-70-4878061
		Address record changed: 2024-04-06

Basic data	Employees	n. a.

		* Document for »About Section«: Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund.

		Record changed: 2024-04-07

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for Asgard Therapeutics AB

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)